Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001274408-04-000001
Filing Date
2004-06-01
Accepted
2004-06-01 16:30:18
Documents
1
Period of Report
2004-05-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 7518
  Complete submission text file 0001274408-04-000001.txt   9363
Mailing Address 790 MEMORIAL DR CAMBRIDGE MA 02139
Business Address 790 MEMORIAL DR CAMBRIDGE MA 02139 6172520700
ALNYLAM PHARMACEUTICALS INC (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARCH VENTURE PARTNERS 8725 W. HIGGINS AVE. #290 CHICAGO IL 60631
Business Address C/O ARCH VENTURE PARTNERS 8725 W. HIGGINS RD #290 CHICAGO IL 60631 7733806600
ARCH VENTURE PARTNERS V LLC (Reporting) CIK: 0001274408 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50743 | Film No.: 04841714